Last reviewed · How we verify

NCT03483298

Split Cohort Trial Comparing IVF Outcomes After the Use of Testicular vs. Ejaculated Sperm for ICSI

Terminated Last updated 28 January 2022
What this trial tests

trial testing ICSI in Infertility in 7 participants. Terminated before completion.

Timeline
23 June 2018
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorReproductive Medicine Associates of New Jersey
StatusTerminated
Study typeOBSERVATIONAL
Enrollment7
Start date23 June 2018
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Reproductive Medicine Associates of New Jersey — full company profile →

Who can join

Adults 18 to 65, male only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to determine if there is a difference in in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) outcomes when using testicular sperm versus ejaculated sperm in couples with elevated sperm DNA fragmentation after a failed in vitro fertilization (IVF) cycle

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ICSI

Trials testing the same drug.

Other recruiting trials for Infertility

Currently open trials in the same condition.

Other Reproductive Medicine Associates of New Jersey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03483298.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing